| scholarly article | Q13442814 |
| P356 | DOI | 10.1192/BJP.116.533.377 |
| P953 | full work available at URL | https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000191238 |
| P698 | PubMed publication ID | 5441795 |
| P2093 | author name string | I. M. Marks | |
| P2860 | cites work | A clinical investigation of phobias | Q39972841 |
| The epidemiology of common fears and phobia. | Q51335670 | ||
| Conditioned eyelid responses in phobic patients | Q51336129 | ||
| Desensitization and phobias: a cross-over study. | Q51340633 | ||
| Desensitization and Psychotherapy in the Treatment of Phobic States: A Controlled Inquiry | Q51345110 | ||
| Modified leucotomy in severe agoraphobia: a controlled serial inquiry. | Q51346360 | ||
| Severe agoraphobia: a controlled prospective trial of behaviour therapy. | Q51347081 | ||
| Autonomic reactivity, eyelid conditioning and their relationship to neuroticism and extraversion | Q52335465 | ||
| Obsessive Compulsive Neurosis in Identical Twins | Q71337391 | ||
| Different ages of onset in varieties of phobia | Q72864818 | ||
| P433 | issue | 533 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 377-386 | |
| P577 | publication date | 1970-04-01 | |
| P1433 | published in | British Journal of Psychiatry | Q4035428 |
| P1476 | title | The classification of phobic disorders | |
| The Classification of Phobic Disorders | |||
| P478 | volume | 116 |
| Q39961245 | ?Frigidity?: A critical review |
| Q33860871 | A European perspective on social anxiety disorder |
| Q66962259 | A Pilot Study of Anafranil in the Treatment of Phobic States |
| Q68062547 | A comparison of patients with illness phobia and panic disorder |
| Q67484761 | A note on classifying phobia |
| Q93752342 | A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety |
| Q51072139 | Administration of high-dose ketoconazole, an inhibitor of steroid synthesis, prevents posttraumatic anxiety in an animal model. |
| Q44041539 | Agoraphobia |
| Q51324141 | Anxiety Associated with Flying: A Retrospective Survey of Military Aircrew Psychiatric Casualties |
| Q70899299 | Augmentation of in vivo exposure treatment for agoraphobia by the formation of neighbourhood self-help groups |
| Q40540265 | Classification and epidemiology of social phobia |
| Q51849731 | Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice |
| Q34193826 | Cross-cultural study of conviction subtype Taijin Kyofu: proposal and reliability of Nagoya-Osaka diagnostic criteria for social anxiety disorder. |
| Q72585454 | Effects of four treatment methods on agoraphobic women not suitable for insight-oriented psychotherapy |
| Q73540522 | Epidemiology of social phobia: a clinical approach |
| Q74588430 | Hypochondriasis vs. anxiety disorders: why should we care? |
| Q66916274 | Letter: Agoraphobia |
| Q70781262 | MAO inhibition and control of anxiety following amitriptyline therapy |
| Q51223757 | Neurosis divisible? |
| Q51322283 | Origins of Disease Phobia |
| Q51210410 | Panic disorder and agoraphobia. |
| Q52120999 | Part 2. A logical analysis of the medico-psychological concept of disease |
| Q59798365 | Phobia of the Supernatural: A Distinct but Poorly Recognized Specific Phobia With an Adverse Impact on Daily Living |
| Q72470481 | Phobic postural vertigo: a first follow-up |
| Q48887380 | Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor |
| Q72561763 | Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine |
| Q39628077 | Psychosocial treatments for social phobia |
| Q35062522 | Self-medication in social phobia: a review of the alcohol literature. |
| Q77070534 | Social anxiety and its effects on performance and perception |
| Q68828094 | Social phobia in Saudis |
| Q36520064 | Social phobias: behavioural and pharmacotherapy |
| Q50879851 | Specific fears and phobias in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). |
| Q37639079 | Specific phobia among U.S. adolescents: phenomenology and typology |
| Q74291642 | Specific phobia of illness in the community |
| Q35776523 | Specific phobia of illness: search for a new subtype |
| Q39957762 | The Relationship between Agoraphobia and Primary Affective Disorders |
| Q39178501 | The Role of Social Anxiety in Social Interaction Difficulties |
| Q48879583 | The Zurich study. XX. Social phobia and agoraphobia |
| Q52034523 | The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. |
| Q28262456 | The evidence-based pharmacotherapy of social anxiety disorder |
| Q33539334 | The relationship of hypochondriasis to anxiety disorders |
| Q51323723 | Thought Stopping: A Useful Treatment in Phobias of ‘Internal Stimuli’ |
| Q34693421 | Treatment of Social Phobia: Potential Mediators and Moderators |
Search more.